Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-20-016161
Filing Date
2020-08-31
Accepted
2020-08-31 13:08:16
Documents
1
Period of Report
2020-08-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3856
  Complete submission text file 0001567619-20-016161.txt   5334
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Unum Therapeutics Inc. (Issuer) CIK: 0001622229 (see all company filings)

EIN.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2001 MARKET STREET SUITE 2500 PHILADELPHIA PA 19103
Business Address
Harwin Peter Evan (Reporting) CIK: 0001663607 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38443 | Film No.: 201150843